Lipid compartments and lipid metabolism as therapeutic targets against coronavirus

被引:3
|
作者
Cesar-Silva, Daniella [1 ]
Pereira-Dutra, Filipe S. [1 ]
Giannini, Ana Lucia Moraes [2 ]
Maya-Monteiro, Clarissa M. [1 ,3 ]
de Almeida, Cecilia Jacques G. [1 ]
机构
[1] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Dept Genet, Lab Immunopharmacol, Rio De Janeiro, Brazil
[2] Univ Fed Rio de Janeiro, Lab Funct Genom & Signal Transduct, Rio De Janeiro, Brazil
[3] Univ Amsterdam, Amsterdam Univ Med Ctr UMC, Dept Endocrinol & Metab, Lab Endocrinol, Amsterdam, Netherlands
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
关键词
lipid nanodomains; caveolae; caveolin; lipid droplets; coronavirus; SARS-CoV-2; lipid metabolism; inflammation; RESPIRATORY SYNDROME-CORONAVIRUS; MEDIATED ENDOCYTIC PATHWAY; CELL-CELL FUSION; SARS-CORONAVIRUS; ENDOPLASMIC-RETICULUM; MEMBRANE CURVATURE; SPIKE GLYCOPROTEIN; CHOLESTEROL EFFLUX; SARS-COV-2; SPIKE; DEPENDENT ENTRY;
D O I
10.3389/fimmu.2023.1268854
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lipids perform a series of cellular functions, establishing cell and organelles' boundaries, organizing signaling platforms, and creating compartments where specific reactions occur. Moreover, lipids store energy and act as secondary messengers whose distribution is tightly regulated. Disruption of lipid metabolism is associated with many diseases, including those caused by viruses. In this scenario, lipids can favor virus replication and are not solely used as pathogens' energy source. In contrast, cells can counteract viruses using lipids as weapons. In this review, we discuss the available data on how coronaviruses profit from cellular lipid compartments and why targeting lipid metabolism may be a powerful strategy to fight these cellular parasites. We also provide a formidable collection of data on the pharmacological approaches targeting lipid metabolism to impair and treat coronavirus infection.
引用
收藏
页数:25
相关论文
共 50 条
  • [41] Progress in therapeutic strategies based on cancer lipid metabolism
    Diao, Xia-Yao
    Lin, Tianxin
    THORACIC CANCER, 2019, 10 (09) : 1741 - 1743
  • [42] Aberrant lipid metabolism as a therapeutic target in liver cancer
    Pope, Evans D., III
    Kimbrough, Erinmarie O.
    Vemireddy, Lalitha Padmanabha
    Surapaneni, Phani Keerthi
    Copland, John A., III
    Mody, Kabir
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2019, 23 (06) : 473 - 483
  • [43] Cholesterol and Sphingolipid Enriched Lipid Rafts as Therapeutic Targets in Cancer
    Codini, Michela
    Garcia-Gil, Mercedes
    Albi, Elisabetta
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (02) : 1 - 17
  • [44] Prioritization of Lipid Metabolism Targets for the Diagnosis and Treatment of Cardiovascular Diseases
    Wang, Zhihua
    Chen, Shuo
    Zhang, Fanshun
    Akhmedov, Shamil
    Weng, Jianping
    Xu, Suowen
    RESEARCH, 2025, 8
  • [45] Lipid metabolism in pancreatic cancer: emerging roles and potential targets
    Yin, Xinpeng
    Xu, Ruiyuan
    Song, Jianlu
    Ruze, Rexiati
    Chen, Yuan
    Wang, Chengcheng
    Xu, Qiang
    CANCER COMMUNICATIONS, 2022, 42 (12) : 1234 - 1256
  • [46] Altered Lipid and Mitochondrial Metabolism Are Viable Targets in Acute Leukemia
    Pardee, Timothy
    DeFord-Watts, Laura M.
    Peronto, Erica
    Levitan, Denise A.
    Hurd, David Duane
    Kridel, Steven
    BLOOD, 2011, 118 (21) : 1546 - 1546
  • [47] Are nuclear factors the ultimate targets of drugs affecting lipid metabolism?
    Fruchart J.C.
    Current Atherosclerosis Reports, 2000, 2 (5) : 353 - 354
  • [48] Tributyltin targets hepatic transcriptional regulation of lipid metabolism in mice
    Wang, Yunxi
    Zhang, Jiliang
    Pan, Mengqi
    TOXICOLOGICAL AND ENVIRONMENTAL CHEMISTRY, 2017, 99 (03): : 492 - 504
  • [49] Lipid metabolism: apolipoprotein variations affecting lipid metabolism
    van Heyningen, C
    CURRENT OPINION IN LIPIDOLOGY, 2005, 16 (05) : 597 - 599
  • [50] Lipid metabolism: thyroid hormone effects on lipid metabolism
    van Heyningen, Charles
    Glaysher, Jennifer
    CURRENT OPINION IN LIPIDOLOGY, 2012, 23 (06) : 584 - 585